6 Spam-Free Article(s) Found
Sort:
Relevance
Filter:
All
Symbol Name Last Close Mkt Cap DailyStocks'
Rating
Our DailyStocks’ Rating System is a proprietary algorithm that combines the vote of the investor community and legendary trader Richard Dennis’ Turtle Trader System and the System Rules of the Turtle Traders Each day, we generate Buy, Sell, Uptrend or Downtrend signals for 3000 Stocks in the U.S. Markets.
Vote Now!
Tuesday’s Close
ARRY Array BioPharma Inc. $14.1 $2.97B N/A
Article Searches
Wells Fargo Projects Sustained Growth For British Telecom Supplier Arris http://feeds.benzinga.com/~r/benzinga/~3/jt1j9bmt0QQ/wells-fargo-projects-sustained-growth-for-british-telec Jul 12, 2018 -

Wells Fargo initiated coverage of ARRIS International plc (NASDAQ: ARRS) with above-consensus estimates for 2018, 2019 and 2020.

Financial & Investment Management Group Ltd Buys Omnicom Group Inc, Blackrock Credit ... http://www.gurufocus.com/news/707541/financial--investment-management-group-ltd-buys-omnicom-group-inc-blackrock-credit-allocation-income-trust-regeneron-pharmaceuticals-inc-sells-schwab-intermediateterm-us-treasury-associated-capital-group-inc-nokia-oyj Jul 13, 2018 - Financial & Investment Management Group Ltd Buys Omnicom Group Inc, Blackrock Credit Allocation Income Trust, Regeneron Pharmaceuticals Inc, Sells Schwab Intermediate-Term U.S. Treasury, Associated Capital Group Inc, Nokia Oyj, Stocks: OMC,BTZ,REGN,HBI,ARRY,IGR,AGIO,FWONK,BRK.A,GDO,FAX, release date:Jul 13, 2018
Biotech Stock Roundup: AMGN Resubmits Evenity BLA, Advaxis Soars, Regulatory Updates http://www.zacks.com/stock/news/311982/biotech-stock-roundup-amgn-resubmits-evenity-bla-advaxis-soars-regulatory-updates?cid=CS-ZC-FT-311982 Jul 18, 2018 - It has been a pretty ho-hum week for the biotech sector with a few regulatory updates. Amgen resubmits BLA for osteoporosis drug and Advaxis surges on positive news from FDA.
Core Biotech Buys #17: Positive Commentary For Gene Therapy And Our First Swap https://seekingalpha.com/article/4178491-core-biotech-buys-17-positive-commentary-gene-therapy-first-swap?source=feed_tag_etf_portfolio_strategy May 31, 2018 - FDA Commissioner Scott Gottlieb´s remarks concerning the potential of gene therapy, bode well for stocks participating in that theme.A clinical hold for CRISPR Therapeutics caused some concern but I p
Key FDA Events in June Investors Need to Watch Out For http://www.zacks.com/stock/news/306171/key-fda-events-in-june-investors-need-to-watch-out-for?cid=CS-ZC-FT-306171 Jun 01, 2018 - Investors in the healthcare industry are likely to keep a watch on upcoming PDUFA dates for key drugs in Jun 2018.
3 Things In Biotech, July 16: Array Gets An Important Update https://seekingalpha.com/article/4187583-3-things-biotech-july-16-array-gets-important-update?source=feed_all_articles Jul 16, 2018 - Array's melanoma combo gets a guideline nod. Atossa looks for a window of opportunity in breast cancer. Astellas and Pfizer score widened approval for Xtandi.

Pages: 1

Page 1

Related Companies

Name Exchange Price Mkt Cap
HRTX Heron Therapeutics, Inc. NASDAQ $38.1 $2.96B
EBS Emergent Biosolutions, Inc. NYSE $59.27 $2.95B
ASND Ascendis Pharma A/S NASDAQ $71.52 $2.99B
MDCO The Medicines Company NASDAQ $39.85 $2.93B
BPMC Blueprint Medicines Corporation NASDAQ $69.69 $3.06B
Sector: Health Care > Industry: Major Pharmaceuticals
DeepLinks for Array BioPharma